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Background: Cannabis use (CU) and disorders (CUD) are highly prevalent among adolescents 
and young adults. We aim to identify clinically meaningful latent classes of users of cannabis 
and other illegal substances with distinct problem profiles.  
Methods: N= 3021 community subjects aged 14–24 at baseline were followed-up over a 
period ranging up to 10 years. Substance use (SU) and disorders (SUD) were assessed with 
the DSM-IV/M-CIDI. Latent class analysis (LCA) was conducted with a subset of N= 1089 
subjects with repeated illegal SU. The variables entered in the LCA were CU-related 
problems, CUD, other SUD, and other mental disorders.  
Results: Four latent classes were identified: “Unproblematic CU” (class 1: 59.2%), “Primary 
alcohol use disorders” (class 2: 14.4%), “Delinquent cannabis/alcohol DSM-IV-abuse” (class 
3: 17.9%), “CUD with multiple problems” (class 4: 8.5%). Range and level of CU-related 
problems were highest in classes 3 and 4. Comorbidity with other mental disorders was 
highest in classes 2 and 4. The probability of alcohol disorders and unmet treatment needs 
was considerable in classes 2–4.  
Conclusion: While the majority of subjects with repeated illegal SU did not experience 
notable problems over the 10-year period, a large minority (40.8%) experienced problematic 
outcomes, distinguished by clinically meaningful profiles. The data underline the need for 
specifically tailored interventions for adolescents with problematic CU and highlight the 
potentially important role of alcohol and other mental disorders.   
 




1. Introduction  
 
Cannabis use (CU) and cannabis use disorders (CUD; DSM-IV-abuse and -dependence) are 
highly prevalent in western countries (Boden et al., 2006; Coffey et al., 2002; Compton et al., 
2004; Perkonigg et al., 2008) and associated with a range of CU-related problems in 
adolescents and young adults as outlined below. Due to a wide range of investigated factors 
and different study designs it has been difficult to translate these findings into clinically 
meaningful guidance for prevention and intervention because of the heterogeneity among 
cannabis users. It has also been difficult to demonstrate to what degree the range and level of 
CU-related problems is associated with CU patterns and CUD. Also, it has been difficult to 
derive a clearer picture of the cannabis-specific clusters of problems that develop during the 
high-incidence phase of CU and CUD in adolescence. This difficulty may partially be the 
result of earlier conceptions of CU as a typically transient phenomenon unrelated to a 
cannabis-specific dependence syndrome unless other problematic substance use (SU) or 
substance use disorder (SUD) occurs. Currently, there is little consensus of whether there is a 
group among subjects with repeated illegal SU that has predominant CUD but no further 
illegal SU/SUD and how large this group may be. Using community data we aim to derive 
clinically meaningful classes of individuals with repeated (at least 5 times) use of illegal 
substances by taking into account CU-related somatic and mental health problems, 
interpersonal problems, violence and delinquency, and occupational/financial problems in the 
first three decades of life.  
 
The high-incidence phase for CU and CUD is in the second decade of life (Behrendt et al., 
2009; Monshouwer et al., 2005; Patton et al., 2002; Vega et al., 2002; Wagner and Anthony, 
2002). There is evidence that CU and CUD frequently persist into adulthood (Perkonigg et al., 
2008; Robertson et al., 1996).  
 
CU in adolescence is associated with a broad range of somatic and mental health issues such 
as affective and anxiety symptoms and disorders, antisocial behaviour, legal and illegal SU 
and alcohol disorders (Degenhardt et al., 2002; Höfler et al., 1999; Patton et al., 2002, 2005; 
Rey et al., 2002; von Sydow et al., 2001; Wittchen et al., 2007; Zimmermann et al., 2005). 
The proportion of users experiencing CU-related problems is considerable but seems to vary 
with CU-frequency and DSM-IV-cannabis abuse or dependence (Caldeira et al., 2007; Nocon 
et al., 2006). The risk of CUD is higher among subjects with early onset of CU (Chen et al., 
2005).  
 
CU and CUD are predicted by and associated with nicotine dependence (Wittchen et al., 
2007). Also, frequent CU predicts smoking (Patton et al., 2005). Conduct problems/disorders 
predict CU and CUD (Wittchen et al., 2007; Boyle et al., 1992; King et al., 2004; Pedersen et 
al., 2001). Also, anxiety, and depression may occur primary (Wittchen et al., 2007) and/or 
secondary to CU (Hayatbakhsh et al., 2007) or CUD (Wittchen et al., 2007). CU and CU-
frequency were further associated with subsequent psychotic symptoms (Henquet et al., 2005) 
and related to poorer educational outcome (Brook et al., 1999; Fergusson et al., 2003; 
Georgiades and Boyle, 2007).  
 
Help-seeking rates of subjects with CU-related problems increased in Germany and other 
European countries until 2005 (European Monitoring Centre for Drugs and Drug Addiction, 
2007; Pfeiffer-Gerschel et al., 2007). At the same time drug services confronted with growing 
numbers of patients struggle with the choice of appropriate interventions and the lack of 
established interventions designed for cannabis-problems. Further, the mere scale of the 
problem in numbers of help-seeking subjects makes it unlikely that treatment offers can be 
allocated to all subjects asking for help. In this situation, data clarifying the question, whether 
subjects with CUD are a homogenous group or whether there are subgroups with distinct 
profiles requiring different interventions might provide some initial guidance. This question 
has also important implications for the development of CUD-specific treatments (Copeland et 
al., 2001; Dennis et al., 2004; Hoch et al., 2007; Stephens et al., 2002) that have recently 
become available from treatment research.  
 
Adult cannabis users differ by CUD symptoms(Grant et al., 2006) and adults with CUD differ 
by concomitant illegal SUD2 (Agrawal et al., 2006). However, the subject remains 
understudied for the high-risk phase for onset of CU and CUD in adolescence and young 
adulthood. We aim to identify subgroups with specific problem profiles in a community 
sample of adolescents and young adults. In this regard we aim to take into account all CU-
related problems and CUD that occurred in the high-risk phase of SU and SUD in this sample. 
Therefore, we considered all CU-related problems and CUD cases that occurred at any 
assessment of the study in order to derive a complete picture of all problems reported in this 
sample in a time period of over up to 10 years that covered the core incidence phase of SU 
and SUD in adolescence.  
 
We aim to  
(1) identify latent classes of subjects with repeated illegal SU by CU-related problems, 
alcohol disorders, other mental disorders and antisocial behaviours;  
(2) further characterize these classes in terms of sex, nicotine dependence, treatment seeking, 
and age at first SU.   
 
2. Methods  
 
2.1. Sample and overall design  
 
Data were collected as part of the EDSP study (Early Developmental Stages of 
Psychopathology Study) a prospective-longitudinal study on the prevalence, course and risk-
factors of SU, SUD and other mental disorders. Detailed descriptions of the sample, the study 
design and objective have been presented elsewhere (Lieb et al., 2000; Wittchen et al., 
1998b). The sample is a community-based sample of N= 3021 subjects aged 14–24 at 
baseline. The study emphasizes early developmental stages of psychopathology. Therefore, 
individuals aged 14–15 years were sampled at twice the probability of those aged 16–21 years 
and individuals aged 22–24 years were sampled at half the probability of those aged 16–21. 
The baseline sample was drawn randomly from metropolitan Munich, Germany government 
registries in 1994 and followed-up over a 10-year period with up to three follow-up 
assessments. The baseline assessment took place in 1995 (T0, N= 3021, response rate 71%). 
The follow-up assessments were carried out 1.6 years (T1, median interval since baseline, 
only for the younger cohort of N= 1228 subjects aged 14–17 at baseline), 3.5 years (T2) and 
8.2 years (T3) later. Conditional response rates (based on T0 participants) were 84.3% (N= 
2548) at T2 and 73.2% (N= 2210) at T3. At T3, the age range was 21–34 years. The latent 
class analysis was conducted with the subset of N= 1089 subjects who reported repeated use 
(5 times or more) of at least one illegal substance at at least one assessment.  
 
We assessed whether repeated CU or repeated other illegal SU at T0 predicted a lower rate of 
maintaining in the sample. In the younger cohort, repeated other illegal SU at baseline 
predicted drop-out at T3 (OR: 0.36, 95% CI: 0.1–0.9, p = 0.031).  
 
2.2. Diagnostic assessment  
 
Participants were assessed with the baseline or respective follow-up interval computer-
assisted versions of the Munich-Composite International Diagnostic Interview (DIA-X/M-
CIDI) (Wittchen et al., 1998a; Wittchen and Pfister, 1997), an updated version of the World 
Health Organisation (WHO) CIDI (Wittchen and Semmler, 1990). The DIA-X/M-CIDI is a 
                                                 
2 In the following text, the terms other illegal SU and other illegal SUD will refer to illegal SU or illegal SUD 
related to illegal drugs except cannabis 
fully standardized diagnostic interview designed for epidemiological research (Wittchen et al., 
1998a). With the DIA-X/M-CIDI, it is possible to assess symptoms, syndromes and diagnoses 
(based on the computerized M-CIDI/DSM-IV algorithms) of 48 mental disorders along with 
information about onset, course, and impairment. The validity and reliability of DIA-X/M-
CIDI diagnoses have been established: Validity was good for SUD (kappa 0.86) and 
reliability was satisfactory to good for any drug disorder (kappa 0.64) (Lachner et al., 1998; 
Reed et al., 1998).  
 
SU and SUD were assessed with the three DIA-X/M-CIDI-sections for nicotine, alcohol, and 
medication and illegal substances, which have been described elsewhere in detail (Behrendt et 
al., 2009; Perkonigg et al., 2008). Diagnostic criteria for SUD were assessed if criteria for 
minimal SU of the respective substance were met. Criteria were (a) daily tobacco use over 4 
weeks and (b) illegal SU at 5 times (for other illegal SUD and CUD; for CU-related 
problems). Alcohol dependence was assessed in case the individual reported alcohol use at 
least 3 times a week in a longer period or more than three standard drinks per drinking day 
during the last 12 months. DSM-IV-alcohol abuse was assessed in case of alcohol use on at 
least 13 occasions in at least 1 year during lifetime. Subjects who did not meet these criteria 
were coded as zero in the SUD-variables. All modes of CU (e.g. joints, bongs) were 
considered. Unfortunately, data did not permit differentiating between CU with and without 
simultaneous tobacco use. Criteria for cannabis dependence included withdrawal but 
endorsement of physical dependence symptoms was no prerequisite for a dependence 
diagnosis. Four substance categories were considered: alcohol, nicotine, cannabis and illegal 
drugs other than cannabis. The following use levels were considered: no use, any use, 
repeated use, DSM-IV-abuse, DSM-IV-dependence (DSM-IV-dependence and -abuse 
diagnoses were non-hierarchical; participants could be given both lifetime diagnoses).  
 
2.3. Statistical analysis  
 
Data were weighted to account for different sampling probabilities at baseline, and response 
rates at baseline varying over age, sex, and geographic location. With the exception of the 
latent class analysis (LCA), the Stata Software package 10.0 (StataCorp., 2007) was used for 
analyses and computing robust variances, confidence intervals, and p-values (by applying the 
Huber–White sandwich matrix) required when performing analyses with weighted data 
(Royall, 1986). Multiple linear regression and multi-nominal logistic regression analyses were 
used to examine associations between latent classes and other variables.  
 
2.3.1. Latent class analysis  
 
LCA (Skrondal and Rabe-Hesketh, 2004) was used to empirically identify the typologies of 
cannabis and other illegal drug users. LCA is a probabilistic method to identify latent groups 
of individuals so that, given group status, the manifest variables entered into the analysis are 
as independent as possible from one another within the latent classes (“local independence”). 
Therefore, LCA seems promising to reduce the probably complex structure of dependencies 
between variables to a single multi-categorical variable. LCA models were calculated using 
the statistical package Mplus, version 5.0 (Muthén and Muthén, 1998–2006).  
 
1000 random sets of starting values were generated in the initial and 30 optimizations were 
carried out in the final stage; calculations were repeated to ensure that the found solution was 
the global maximum of the likelihood function. We fitted models with three to seven classes. 
Model fit was assessed with the Bayesian information criterion (BIC), the sample size 
adjusted BIC (ABIC), and Akaikes information criterion (AIC), the most common indices 
which reveal a compromise between model fit and model parsimony (low number of 
parameters). Lower BIC, ABIC and AIC values indicate a better model fit. In addition, model 
fit was assessed with the Lo Mendell Rubin Adjusted Likelihood Ratio Test (LMR) 
comparing the actual model with one class less. Class membership was estimated using 
maximum posterior probabilities.  
 
2.3.1.1. Variables in the LCA. Variables in the LCA were coded as 1 if a problem occurred at 
any wave, regardless of later remission or drop-out. Findings were combined across 
assessment waves. The variables on CU-related problems were composed of problem items 
from the SUD-section of the DIA-X/M-CIDI. CU-problems had to occur in relation with CU, 
not in relation with other SU. This ensures that problems reported by users of illegal 
substances were related to cannabis. Whether a problem was due to CU was decided by the 
participants. CU-related problems were defined as:  
 
(1) CU-related mental health problems: CU-related psychological problems.  
(2) CU-related somatic health problems: Injuries and somatic health problems because of CU.  
(3) CU-related interpersonal problems: Termination of a close relationship; reproach by close 
persons because of CU.  
(4) CU-related violence and delinquency (subsequently referred to as “legal problems”): CU-
related legal problems; CU in a physically dangerous situation; committed physical assault.  
(5) CU-related occupational and financial problems (subsequently referred to as “occupational 
problems”): Financial problems; failure to fulfil role obligations at home, in school or at 
work; giving up important social, occupational or recreational activities.  
(6) Two or more mental disorders other than SUD: The following disorders were considered: 
major depression, dysthymia, bipolar disorder I and II, social phobia, any specific phobia, 
panic disorder, agoraphobia without a history of panic disorder, generalized anxiety disorder, 
posttraumatic stress disorder, obsessive–compulsive disorder, pain disorder, hypochondriasis, 
SSI4/6 (four somatoform symptoms endorsed by males, six somatoform symptoms endorsed 
by females), anorexia nervosa, bulimia nervosa, any psychotic disorder.  
(7) Other variables used in the LCA: Antisocial behaviour,3 DSM-IV-alcohol abuse, alcohol 
dependence, DSM-IV-cannabis abuse, cannabis dependence, other illegal drug abuse and 
other illegal drug dependence (DSM-IV-abuse and dependence were non-hierarchical).  
 
2.3.1.2. Latent class characterization. To further characterize the latent classes, firstly a 
dimensional measure of the number of lifetime occasions of CU and of other illegal SU was 
transformed into a dichotomous variable and used in the logistic regressions analysis. Reports 
were gathered from the 794 individuals who provided information on the number of lifetime 
experiences of illegal SU at T2 and/or T3 (this information was not available from other 
waves), for other subjects it had to be coded as missing and those coded as missing were 
omitted from the analysis. In case that an individual reported different numbers of occasions 
of illegal SU at T2 and T3, the higher number of occasions reported was taken into account. 
Three dichotomous variables were created based on the dimensional measure: (1) other illegal 
SU on <10 occasions vs. ≥10 occasion, (2) other illegal SU on ≤100 occasions vs. on >100 




                                                 
3 Antisocial behavior was assessed with questionnaires at first (parental information on conduct disorder) and 
second follow-up (participant information on conduct disorder and anti-social personality disorder). For the 
present analysis, both diagnoses were collapsed into one category labelled “Antisocial behavior”, using 
information from subjects who had participated at first and/or second follow-up. 
3. Results  
 
3.1. The LCA solution  
 
Table 1 shows the fit indices for three to seven latent classes. According to the LMR only the 
three class solution was better than the two class solution. The BIC was smallest for four 
latent classes. The AIC and the ABIC were smallest for seven latent classes. This seven class 
solution, however, included three very similar classes. Using tetrachorical correlations we 
found dependencies of the class indicators within classes for all solutions (results available 
upon request).We then tested whether the solutions could be replicated when adjusting the 
classification for sex and age at last assessment. If LCA adjusted for socio-demographic 
variables yields different patterns this would indicate that the local independence assumption 
is violated resulting in a potentially wrong solution (results available on request). Only the 
four class solution remained stable. Therefore, we chose the four class solution.  
 
3.2. Class characteristics  
 
Class 1 (“Unproblematic CU”; 59.21%): In the largest of the four classes, individuals had 
very low estimated probabilities for CUD, CU-related somatic health, mental health, legal, 
and occupational problems and other illegal SUD (0.0–1.9%). Probabilities of CU related 
interpersonal problems, alcohol disorders, burden of mental disorders, and antisocial 
behaviour were comparable to those in the entire sample or lower (see Table 2).  
 
Class 2 (“Primary alcohol use disorders”; 14.36%): In this class, no one fulfilled criteria for 
DSM-IV-cannabis abuse and estimated probabilities of cannabis dependence were 
comparable to those in the entire sample (4.2%). However, rates were considerable for CU-
related interpersonal and mental health problems (23.0% and 27.5%), elevated for 
occupational (6.6%) and somatic health problems (13.3%) in comparison to class 1, but only 
1.3% for legal problems. Compared to class 1, this class had high relative frequencies of 
DSM-IV-alcohol use disorders (61.0–79.0%) and elevated relative frequencies of antisocial 
behaviour, other illegal SUD and having ≥two mental disorders (43.9%).  
 
Class 3 (Delinquent cannabis/alcohol DSM-IV-abuse; 17.90%): All class members fulfilled 
criteria for DSM-IV-cannabis abuse (100%) and many met DSM-IV-alcohol abuse criteria 
(60.9%). Rates for all CU-related problems were elevated, especially for legal (85.3%) and 
interpersonal problems (51.3%).  
 
Class 4 (“CUD with multiple problems”; 8.53%): This class had high rates for DSM-IV-
cannabis abuse (92.7%) and dependence (82.7%). It also had the most distinct CU-related 
problem profile, with high frequencies for the entire problem-range (62.0–91.5%). Class 4 
had the highest rate of having two or more mental disorders other than SUD (59.0%). The 
frequencies of antisocial behaviours and alcohol disorders were strongly elevated in 
comparison to class 1. Probabilities for other illegal drug dependence were elevated in 
comparison to class 1 but comparable to those in class 2.  
 
3.3. Further class characteristics  
 
We assessed whether the four derived classes allowed to distinguish between variables not 
entered in the LCA. For the description of rates and for multiple logistic and linear regression 
analyses, we chose class 1 (“Unproblematic CU”) as a comparison group (for rates see Table 
3, for results of the multiple logistic regression analysis see Table 4; results of the multiple 
linear regression analysis are given in the text).  
 
Age: Multiple linear regression revealed that subjects in classes 3 and 4 had a lower baseline 
age (Mean difference (MD) =−1.20, 95% CI: −1.7 to −0.6; MD=−1.00, 95% CI: −1.8 to −0.2; 
respectively) and a lower maximum age over assessments (MD=−1.53; 95% CI: −2.2 to−0.9; 
MD=−1.20; 95% CI:−2.1 to−0.3; table available upon request).  
 
Sex: The rate of being female was highest in classes 1 (50.3%). Multiple logistic regression 
showed that females were less likely to fall into classes 2–4.  
 
Frequency of illegal SU: Multiple logistic regression revealed that the risk of CU at more than 
200 occasions and the risk of other illegal SU on ten or more occasions was elevated in 
classes 2–4.  
 
Nicotine dependence: The rate of lifetime nicotine dependence was higher in classes 2–4.  
 
Treatment: A large proportion (45.9–69.9%) of subjects in classes 2–4 did not receive any 
treatment. Any treatment seeking was more likely in class 4. Also having contacted a 
psychotherapist was more likely in class 4. However, the rate of untreated cases in this class 
was 45.9%.  
 
Age at first SU: The relation between age-of-onset of SU (outcome) and classes (independent 
variable) was assessed with multiple linear regression analyses. Subjects in class 2 had an 
aver-age 0.71 years earlier onset of alcohol use (95% CI: 0.2–1.2). This was also found for 
classes 3 and 4 (0.85, 95% CI: 0.4–1.3 and 0.70, 95% CI: 0.07–1.3). First nicotine use 
occurred earlier in classes 2 and 4 (0.60, 95% CI: 0.03–1.2 and 0.49, 95% CI: 0.01–1.0). First 
use of cannabis occurred earlier in classes 2–4 (class 2: 1.11, 95% CI: 0.6–1.6; class 3: 1.18, 
95% CI: 0.8–1.5; class 4: 1.86, 95% CI: 1.3–2.4) (table available upon request).  
 
4. Discussion  
 
This study aimed to identify subgroups of cannabis users in adolescence and young adulthood 
by taking into account various problems that occurred in the period covering the high-risk 
phase of incident SU and SUD. The main findings are:  
 
(1) A large proportion (59.2%) was classified as “non-problematic”, while 40.8% were 
classified as problematic users, (2) classes with elevated problem probabilities differed by 
problem profiles possibly indicating different treatment needs, (3) the “problematic” classes 
(2–4) differed from the “unproblematic CU” class by SU onset, nicotine dependence and SU 
frequency, (4) classes with problematic CU had elevated probabilities of alcohol disorders. 
Some had high probabilities of other mental disorders.  
 
4.1. Methodological aspects  
 
Before discussing the results in detail, methodological aspects should be addressed. We found 
some violations of local independence when examining the correlation structure within all 
classes in all LCA solutions. However, the 4 class solution presented here was stable when 
covariates were added indicating robustness against the violated local independence 
assumption. However, the six class solution appeared to be very interesting. In comparison to 
the four class solution, it offered a differentiation between problem profiles characterized by 
either CUD alone or CUD with other illegal SUD. This may be regarded as an evidence of 
further possible differentiations between subgroups of adolescents with CU. In larger and 
more heterogeneous datasets, it may be possible to observe these additional subgroups.  
 
4.2. Subgroup proportions and profiles  
 
We found that the majority of subjects with repeated illegal SU did not report many CU-
related problems, while a considerable 40.8% developed a problematic profile. Information on 
age indicates that the “Unproblematic CU” class does not simply consist of subjects who have 
not developed the problems yet. In conclusion, not all subjects with repeated illegal SU do 
necessarily develop problems. By taking into account other salient and public-health relevant 
problems we showed that the non-problematic group had low probabilities for all investigated 
problem areas. Females were more likely to be in the “non-problematic” class which is in 
agreement with LCAs conducted with adult data (Agrawal et al., 2006; Grant et al., 2006) and 
the greater risk of CUD in males (Compton et al., 2004; von Sydow et al., 2001; Wagner and 
Anthony, 2007). One may speculate that the different problem profiles may reflect a 
continuum of clinical severity for repeated illegal SU. However, the high rates of alcohol use 
disorders combined with low rates of cannabis use disorders in class 2 may also indicate that 
for some subjects not cannabis but alcohol is the substance of choice. Thus, class 2 would not 
represent a lower degree of CU-problem severity but a subgroup with primarily alcohol-
related problems. In comparison to the “Unproblematic CU”-class, all “problematic” classes 
had a lower average age of onset of CU. This may support the conceptualization of early SU 
as a general indicator of adolescent problem behaviours (McGue and Iacono, 2008).  
 
In all “problematic” classes, frequencies of alcohol disorders were elevated. Subjects seeking 
drug treatment for cannabis were more likely to report problems with a second substance, 
most likely alcohol (Urbanoski et al., 2005). Also, alcohol dependence predicts stability of 
CU (Perkonigg et al., 2008). Thus, alcohol disorders should merit careful attention in CUD 
treatment. However, this issue is not explicitly addressed in the design of new CUD 
interventions (Copeland et al., 2001; Dennis et al., 2004; Hoch et al., 2007; The Marijuana 
Treatment Project Research Group, 2004). Also, the probabilities for nicotine dependence 
were elevated in all “problematic” classes. Among cannabis users, nicotine users had higher 
odds of cannabis dependence and CU-related problems (Caldeira et al., 2007). Thus nicotine 
use and dependence should be targeted in interventions for CUD. Nicotine and cannabis may 
be used simultaneously, but this information was not available in the dataset. Following the 
assumption that nicotine as an addictive substance may serve as a strong reinforcer for CU if 
the two substances are used simultaneously, this issue deserves further follow-up.  
 
In class 2 (“Primary alcohol use disorders”) subjects had low rates of CUD but elevated rates 
for CU-related problems. Comparable results have been reported (Caldeira et al., 2007; 
Degenhardt et al., 2002). Thus, CU-related problems may occur in the absence of CUD and 
the respective subjects may profit from interventions as harm reduction strategies (Degenhardt 
et al., 2002; Toumbourou et al., 2007). We covered the entire high-risk-phase for CU and 
CUD in this sample (Behrendt et al., 2009). Thus, subjects in this class may not represent 
early stages of CU-problem development but a less severe, possibly stable form of CU-related 
problems as found for subclinical alcohol disorders (Bucholz et al., 2000). However, the 
elevated probability of mental disorders may put this group at risk for later CUD (von Sydow 
et al., 2002; Wittchen et al., 2007) or further mental health complications. With regard to the 
high rates of alcohol use disorders in this subgroup, it may also be the case that this class 
represents a group which is severely affected by SUD but for whom alcohol, not cannabis is 
the drug of choice.  
 
The most severely affected group was class 4. Interestingly, this class was characterized by 
especially high probabilities for CUD and all CU-related problems. Also, the high 
probabilities for alcohol use disorders are notable. Probabilities of other illegal SUD were 
elevated, especially for DSM-IV-abuse (29.2%). However, differences between probabilities 
of CUD and other illegal SUD seem to indicate that a substantial proportion in this group did 
not make a further transition from CUD to other illegal SUD in the high incidence phase of 
other illegal SUD (Wittchen et al., 2008) in spite of early CU-onset and high CU-frequencies. 
This is somewhat surprising, since CU, early CU onset and CU-frequency have been linked to 
other illegal SU (Fergusson et al., 2006; Lynskey et al., 2006; Zimmermann et al., 2005). The 
profile of this group indicates considerable treatment need, but actual treatment rates did not 
exceed 54%, indicating unmet needs. This is surprising since SU-related problems are 
associated with treatment seeking and consideration to change (Annaheim et al., 2007; Wu et 
al., 2003).  
 
Class 4 was characterized by a lower age at first CU and more frequent CU. Subjects with 
these features may profit from interventions supporting the decision process towards change 
(Miller and Rollnick, 2002). Notably, the burden of other mental disorders in this group is 
high. Other mental disorders are highly prevalent in subjects seeking CUD treatment (Dennis 
et al., 2004) and associated with treatment seeking (Perkonigg et al., 2006). Also, the 
considerable probability of alcohol disorders in this group deserves attention as does the 
probability of other illegal SUD. For example, alcohol abuse was related to more negative 
CU-consequences in treatment-seeking adults (Stephens et al., 1993). Treatments for 
CU/CUD are effective without explicitly focusing on other mental disorders (Copeland et al., 
2001), but approaches addressing problems besides CU may be more successful (The 
Marijuana Treatment Project Research Group, 2004), especially with regard to long-term 
outcomes (Dennis et al., 2004).  
 
4.3. Future research  
 
This study served as a first exploratory investigation of global subtypes of cannabis and other 
illegal substance users in adolescence and young adulthood. In future research it would be of 
interest to investigate possible further subgroups of subjects with multiple CU-related 
problems and high CUD-probabilities with regard to further (illegal) SU involvement. In this 
regard, it would be of interest to investigate cognitive control processes (Bühringer et al., 
2008) in CU-problem profiles and CUD. The role of alcohol disorders for CU and CUD 
should be investigated. Research should address how nicotine and alcohol disorders can be 
targeted in CUD-treatment. Future research should identify specific mental disorders in 
subgroups of cannabis users. In keeping with DSMIV nomenclature DSM-IV-abuse and -
dependence are investigated separately and categorically. However, there is evidence that the 
two disorders are part of a latent continuum of substance use severity (Saha et al., 2007). The 
high probabilities for both CUD in class 4 may support this assumption. Also, the high 
probabilities of CU related problems in the class with highest probabilities of CUD may 
indicate the possible meaningfulness of an additional dimensional approach for CUD 
diagnoses to address the issue of severity.  
 
4.4. Limitations  
 
Several limitations should be noted. First, the results do not provide information on subgroup 
development over time and the sequence of problem incidence. Also, we did not take into 
account differences in the chronicity of mental disorders. Second, data were derived from 
metropolitan Munich, a relatively wealthy region in Germany. In this region, attitudes towards 
alcohol and nicotine use are relatively liberal but illegal drug use is prohibited. Thus, our 
findings cannot necessarily be generalized to other regions (e.g. regions with more restrictive 
SU policies). Third, we did not focus on specific mental disorders such as anxiety or mood 
disorders.  
 
In summary, we could identify clinically meaningful subgroups of subjects with repeated 
illegal SU indicating different treatment needs and the necessity of considering comorbid 
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